CurifyLabs was featured on the latest Pharmacy Profit Summit Live Recap Show, Part Two, hosted by Todd Eury on the Pharmacy Podcast Network. Recorded live in Dallas at the Pharmacy Profit Summit 2026, the episode brings "man on the street" conversations with the speakers, vendors, and pharmacy owners who are actively working to grow their businesses outside of traditional PBM revenue streams.
In our segment, Armawn Asgari from CurifyLabs sat down with Pete Nagel, owner of Allcare Pharmacy and Compounding in Lyons, Georgia. Pete has been a pharmacy owner for nearly a decade and now runs a full-service non-sterile compounding pharmacy that ships to seven states. The conversation centered on a simple but consequential question: what changes when precision dosing and automation become part of an everyday compounding workflow?
Quality assurance, every time
One of Pete's first points was about consistency. In a traditional compounding lab, quality assurance is often done on a sample of a batch. With CurifyLabs, every dose is verified — every tablet, troche, and gel tablet — which gives prescribers added confidence in what they're sending to their patients. That confidence has translated into real business growth: Pete now hosts provider nights where local doctors come in to see the technology in action, which has helped Allcare build credibility with referral partners.
Throughput that frees staff for higher-value work
Armawn walked through how automated dosing changes the day-to-day in a compounding lab. Where a technician might previously spend 30 minutes producing 30 doses of a particular preparation by hand — heating bases, eyeballing volumes, working with a hot plate and beaker — automation can complete 100 doses in 5 to 10 minutes. The bigger story isn't just speed: it's what staff get back. Technicians can move on to the next preparation, focus on patient-facing work, or spend time on outreach to local providers — work that grows the business in ways manual dosing can't.
GMP-manufactured bases
A point Armawn emphasised is that CurifyLabs' excipient bases are GMP-manufactured — a standard required for compounding inputs in Europe but uncommon in the US, where GMP is typically applied only to APIs. Combined with CurifyLabs' validated formulation library, this gives pharmacies a fully validated workflow, from base to finished dose.
A real return on investment
Pete spoke openly about ROI. Between labour savings, the ability to scale his existing compound offerings (HRT, NAD troches, low-dose naltrexone, progesterone, and more), and the doors the technology has opened with local prescribers, his investment has paid back faster than he expected. He framed the printer not as an expense but as an investment — one that has let him focus less on monetising every interaction and more on improving the quality of life of the patients his pharmacy serves.
Audit-ready by design
Every print is logged in a cloud-based audit trail — capturing who printed what, and when. As Armawn put it, this is the kind of system that turns Board of Pharmacy inspections from a stressful event into something pharmacies are ready and even excited to show.
A great episode all around
The full episode is well worth a listen. Beyond our conversation, Todd interviews Christopher Flores (Payment Processing), Doug Soupon (RxOneShop), Fiona Sartoretto Verna, and Omar of Utopia Pharmacy — all bringing valuable perspectives on growing an independent pharmacy in 2026.